Agilent Obtains U.S. FDA Approval for GenetiSure Dx Postnatal Assay
Agilent Technologies Inc. has announced that it has obtained 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the GenetiSure Dx Postnatal Assay: its first…
Read More...
Read More...